Teladoc Health Inc (TDOC)
12.75
-0.64
(-4.78%)
USD |
NYSE |
Apr 30, 16:00
12.68
-0.07
(-0.55%)
Pre-Market: 06:35
Teladoc Health Cash from Investing (Quarterly): -35.51M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.51M |
| December 31, 2023 | -36.51M |
| September 30, 2023 | -37.65M |
| June 30, 2023 | -36.57M |
| March 31, 2023 | -45.62M |
| December 31, 2022 | -53.89M |
| September 30, 2022 | -41.45M |
| June 30, 2022 | -44.84M |
| March 31, 2022 | -27.57M |
| December 31, 2021 | -20.08M |
| September 30, 2021 | -34.71M |
| June 30, 2021 | -2.168M |
| March 31, 2021 | -16.03M |
| December 31, 2020 | -413.92M |
| September 30, 2020 | -155.46M |
| June 30, 2020 | -9.662M |
| March 31, 2020 | -11.93M |
| December 31, 2019 | 9.547M |
| September 30, 2019 | 13.19M |
| June 30, 2019 | -5.064M |
| March 31, 2019 | 7.336M |
| Date | Value |
|---|---|
| December 31, 2018 | -42.35M |
| September 30, 2018 | 0.461M |
| June 30, 2018 | -239.58M |
| March 31, 2018 | 23.97M |
| December 31, 2017 | 8.342M |
| September 30, 2017 | -439.86M |
| June 30, 2017 | 4.128M |
| March 31, 2017 | -20.99M |
| December 31, 2016 | 13.71M |
| September 30, 2016 | -11.69M |
| June 30, 2016 | 12.05M |
| March 31, 2016 | 12.07M |
| December 31, 2015 | 14.27M |
| September 30, 2015 | -104.61M |
| June 30, 2015 | -13.79M |
| March 31, 2015 | -4.068M |
| December 31, 2014 | -0.503M |
| September 30, 2014 | -0.258M |
| June 30, 2014 | -14.42M |
| March 31, 2014 | -0.401M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-413.92M
Minimum
Dec 2020
13.19M
Maximum
Sep 2019
-50.29M
Average
-35.11M
Median
Cash from Investing (Quarterly) Benchmarks
| Omnicell Inc | -12.37M |
| Phreesia Inc | -8.158M |
| 10x Genomics Inc | 13.10M |
| Biote Corp | 19.00M |
| American Shared Hospital Services | -0.097M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.92M |
| Cash from Financing (Quarterly) | 1.751M |
| Free Cash Flow | 199.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1585 |
| Free Cash Flow to Equity (Quarterly) | -27.45M |
| Free Cash Flow to Firm (Quarterly) | -26.59M |
| Free Cash Flow Yield | 9.44% |